(1R,2R,4R,7R,10R)-2,7,11,11-tetramethyl-3,12-dioxatetracyclo[8.2.1.01,7.02,4]tridecane

Details

Top
Internal ID 9bbcda0d-6bbb-4f4f-a286-1a5ec2784f39
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids > Agarofurans
IUPAC Name (1R,2R,4R,7R,10R)-2,7,11,11-tetramethyl-3,12-dioxatetracyclo[8.2.1.01,7.02,4]tridecane
SMILES (Canonical) CC1(C2CCC3(CCC4C(C3(C2)O1)(O4)C)C)C
SMILES (Isomeric) C[C@]12CC[C@@H]3C[C@@]1([C@]4([C@H](O4)CC2)C)OC3(C)C
InChI InChI=1S/C15H24O2/c1-12(2)10-5-7-13(3)8-6-11-14(4,16-11)15(13,9-10)17-12/h10-11H,5-9H2,1-4H3/t10-,11-,13-,14-,15-/m1/s1
InChI Key SMVQLPPNRFDHMB-OKNSCYNVSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H24O2
Molecular Weight 236.35 g/mol
Exact Mass 236.177630004 g/mol
Topological Polar Surface Area (TPSA) 21.80 Ų
XlogP 2.50
Atomic LogP (AlogP) 3.29
H-Bond Acceptor 2
H-Bond Donor 0
Rotatable Bonds 0

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (1R,2R,4R,7R,10R)-2,7,11,11-tetramethyl-3,12-dioxatetracyclo[8.2.1.01,7.02,4]tridecane

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9933 99.33%
Caco-2 + 0.8639 86.39%
Blood Brain Barrier + 0.9000 90.00%
Human oral bioavailability + 0.6429 64.29%
Subcellular localzation Mitochondria 0.3924 39.24%
OATP2B1 inhibitior - 0.8502 85.02%
OATP1B1 inhibitior + 0.9359 93.59%
OATP1B3 inhibitior + 0.9681 96.81%
MATE1 inhibitior - 0.8600 86.00%
OCT2 inhibitior - 0.7750 77.50%
BSEP inhibitior - 0.9563 95.63%
P-glycoprotein inhibitior - 0.9105 91.05%
P-glycoprotein substrate - 0.8731 87.31%
CYP3A4 substrate + 0.5388 53.88%
CYP2C9 substrate - 0.6370 63.70%
CYP2D6 substrate - 0.7389 73.89%
CYP3A4 inhibition - 0.9537 95.37%
CYP2C9 inhibition - 0.6697 66.97%
CYP2C19 inhibition - 0.5185 51.85%
CYP2D6 inhibition - 0.9185 91.85%
CYP1A2 inhibition - 0.5840 58.40%
CYP2C8 inhibition - 0.7359 73.59%
CYP inhibitory promiscuity - 0.8579 85.79%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.7400 74.00%
Carcinogenicity (trinary) Non-required 0.6197 61.97%
Eye corrosion - 0.9605 96.05%
Eye irritation + 0.5291 52.91%
Skin irritation - 0.7256 72.56%
Skin corrosion - 0.9343 93.43%
Ames mutagenesis - 0.7000 70.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5252 52.52%
Micronuclear - 0.7000 70.00%
Hepatotoxicity - 0.5779 57.79%
skin sensitisation - 0.6159 61.59%
Respiratory toxicity - 0.5222 52.22%
Reproductive toxicity - 0.7000 70.00%
Mitochondrial toxicity - 0.6125 61.25%
Nephrotoxicity + 0.6419 64.19%
Acute Oral Toxicity (c) III 0.6466 64.66%
Estrogen receptor binding - 0.5200 52.00%
Androgen receptor binding + 0.6217 62.17%
Thyroid receptor binding + 0.5419 54.19%
Glucocorticoid receptor binding - 0.6468 64.68%
Aromatase binding + 0.6478 64.78%
PPAR gamma - 0.6472 64.72%
Honey bee toxicity - 0.8218 82.18%
Biodegradation - 0.6750 67.50%
Crustacea aquatic toxicity - 0.5000 50.00%
Fish aquatic toxicity + 0.8484 84.84%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 91.80% 97.25%
CHEMBL3137262 O60341 LSD1/CoREST complex 90.95% 97.09%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 89.63% 96.09%
CHEMBL218 P21554 Cannabinoid CB1 receptor 86.46% 96.61%
CHEMBL259 P32245 Melanocortin receptor 4 86.10% 95.38%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 84.49% 91.11%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 83.77% 97.14%
CHEMBL1994 P08235 Mineralocorticoid receptor 81.91% 100.00%
CHEMBL1937 Q92769 Histone deacetylase 2 80.99% 94.75%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Alpinia japonica

Cross-Links

Top
PubChem 11770472
LOTUS LTS0266604
wikiData Q105256194